Open-label trial with artemether-lumefantrine against uncomplicated <it>Plasmodium falciparum</it> malaria three years after its broad introduction in Jimma Zone, Ethiopia
<p>Abstract</p> <p>Background</p> <p>In Jimma Zone, Ethiopia, the first-line treatment of uncomplicated falciparum malaria has been changed from sulphadoxine-pyrimethamine (SP) to artemether-lumefantrine (AL) in 2006. The objective of this study was to assess the effect...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-07-01
|
| Series: | Malaria Journal |
| Subjects: | |
| Online Access: | http://www.malariajournal.com/content/11/1/240 |